Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD)

Fig. 2

CS + LPS increases nILC2s and iILC2s in lungs, and IL-13/IL-4 in BALF. (A) Flow cytometry analysis of iILC2s (Lin−CD45+CD127+ST2−KLRG1hi) and nILC2s (Lin–CD45+CD127+ST2+KLRG1int) in the whole lung. The representative gates in each group were exhibited. (B) Percentage of nILC2s in these groups. (C) Percentage of iILC2s in these groups. (D) ELISA was used to detect the concentrations of cytokines IL-13 and IL-4 in BALF. *P < 0.05, **P < 0.01 and ***P < 0.001 (n = 5)

Back to article page